Cosmo Pharmaceuticals N.V. (SWX:COPN)
Switzerland · Delayed Price · Currency is CHF 119.20
-1.40 (-1.16%)
Feb 20, 2026, 5:31 PM CET
Cosmo Pharmaceuticals Market Cap
Cosmo Pharmaceuticals has a market cap or net worth of 1.92 billion as of February 20, 2026. Its market cap has increased by 87.77% in one year.
Market Cap
1.92B
Enterprise Value
1.81B
Revenue
170.24M
Ranking
n/a
PE Ratio
35.20
Stock Price
119.20
Market Cap Chart
Since March 12, 2007, Cosmo Pharmaceuticals's market cap has increased from 194.90M to 1.92B, an increase of 886.26%. That is a compound annual growth rate of 12.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 1.92B | 14.64% |
| Dec 30, 2025 | 1.68B | 64.05% |
| Dec 30, 2024 | 1.02B | 24.91% |
| Dec 29, 2023 | 818.27M | -18.39% |
| Dec 30, 2022 | 1.00B | -9.22% |
| Dec 30, 2021 | 1.10B | -10.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 293.65B |
| Novartis AG | 241.34B |
| Lonza Group AG | 37.80B |
| Galderma Group AG | 36.70B |
| Medacta Group | 3.02B |
| Tecan Group AG | 1.70B |
| SKAN Group AG | 1.21B |
| Medartis Holding AG | 1.17B |